ACM
IDXX icon

Arlington Capital Management’s Idexx Laboratories IDXX Stock Holding History

Arlington Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-479
Closed -$269K – 135
2026
Q1 		$269K Buy
479
+22
+5% +$14.1K 0.15% 85
2025
Q4 		$309K Buy
457
+35
+8% +$23.8K 0.19% 66
2025
Q3 		$270K Buy
+422
New +$256K 0.17% 76

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Arlington Capital Management's IDXX Position: Q2 2026 in Review

Arlington Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 479 shares — an estimated $269K sold.

Arlington Capital Management first reported a position in IDXX in Q3 2025 and held it in 3 quarters. The position peaked at $309K in Q4 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Arlington Capital Management reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Arlington Capital Management sold 479 Idexx Laboratories shares in Q2 2026, an estimated $269K.
  • Arlington Capital Management first reported a position in Idexx Laboratories in Q3 2025 and held it in 3 quarters.
  • Arlington Capital Management's Idexx Laboratories position peaked at $309K in Q4 2025.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Arlington Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.